Wysokinski, Tomasz W.; Chapman, Dean; Adams, Gregg; Renier, Michel; Suortti, Pekka et al. (2007). Beamlines of the biomedical imaging and therapy facility at the Canadian light source—Part 1. Nuclear Instruments and Methods in Physics Research. Section A: Accelerators. Spectrometers. Detectors and Associated Equipment 582(1) , 73-76. 10.1016/j.nima.2007.08.087. |
BMIT-BM, BMIT-ID |
Peer-Reviewed Article |
Health |
Wysokinski, T.W.; Ianowski, J.P.; Luan, X.; Belev, G.; Miller, D. et al. (2016). BMIT facility at the Canadian Light Source: Advances in X-ray phase-sensitive imaging. Physica Medica 32(12) , 1753-1758. 10.1016/j.ejmp.2016.07.090. |
BMIT-BM, BMIT-ID |
Peer-Reviewed Article |
Health |
Mundboth, Kiran (2025). Canadian Light Source – 20 Years of Discovery. Canadian Journal of Chemistry . 10.1139/cjc-2024-0278. |
BMIT, BXDS, CMCF, FAR-IR, HXMA, MID-IR, SM |
Peer-Reviewed Article |
Health |
Diedrich, Camila; Zittlau, Isabella C.; Khalil, Najeh M.; Leontowich, Adam F. G.; Freitas, Rilton A. de et al. (2023). Optimized Chitosan-Based Nanoemulsion Improves Luteolin Release. Pharmaceutics 15(6) , 1592. 10.3390/pharmaceutics15061592. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Thomas (2025). Crystal structure of sparsentan, C32H40N4O5S. Powder Diffraction 40(2) , 157-161. 10.1017/s0885715625000132. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of iprodione, C13H13Cl2N3O3. Powder Diffraction , 1-5. 10.1017/s0885715625100742. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of flumethasone, C22H28F2O5. Powder Diffraction , 1-6. 10.1017/s0885715625000120. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of diroximel fumarate, C11H13NO6. Powder Diffraction , 1-6. 10.1017/s0885715625000119. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of etrasimod, C26H26F3NO3. Powder Diffraction , 1-6. 10.1017/s0885715625000107. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2024). Crystal structure of racemic benserazide hydrochloride Form I, C10H16N3O5Cl. Powder Diffraction , 1-7. 10.1017/s0885715624000496. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2024). Crystal structure of gepirone, C19H29N5O2. Powder Diffraction , 1-6. 10.1017/s0885715624000514. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of repotrectinib, C18H18FN5O2. Powder Diffraction , 1-6. 10.1017/s0885715625100882. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of palovarotene, C
27
H
30
N
2
O
2
. Powder Diffraction , 1-6. 10.1017/s0885715625100869. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of givinostat hydrochloride monohydrate Form I, C
24
H
28
N
3
O
4
Cl(H
2
O). Powder Diffraction , 1-6. 10.1017/s0885715625100559. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). A proposed crystal structure of fruquintinib Form I, C21H19N3O5. Powder Diffraction , 1-7. 10.1017/s0885715625100808. |
BXDS-WLE |
Peer-Reviewed Article |
Health |